SANGAMO THERAPEUTICS, INC (SGMO) Net Cash Provided by (Used in) Financing Activities USD 2011 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Sangamo Therapeutics, Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2011 to 2024.
  • Sangamo Therapeutics, Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $22.1 M, a 176% increase year-over-year.
  • Sangamo Therapeutics, Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $14.6 M, a 82.8% decline from 2022.
  • Sangamo Therapeutics, Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $84.7 M, a 158% increase from 2021.
  • Sangamo Therapeutics, Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $32.9 M, a 78.5% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $22.1 M +$14.1 M +176% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $8 M +$9.57 M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 -$1.57 M -$16.8 M -110% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q1 2021 $15.2 M +$14.8 M +3625% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $409 K +$193 K +89.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q1 2019 $216 K -$10.4 M -98% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 $10.6 M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2014 $101 M +$99.1 M +4411% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-07
Q1 2013 $2.25 M +$2.14 M +1981% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q1 2012 $108 K -$739 K -87.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q1 2011 $847 K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.